Code of Ethics January 2019 Revision

International Pharmaceutical Manufacturers Group (IPMG), is a non-profit, non-governmental organization representing 25 international research-based pharmaceutical companies operating in Indonesia, has been steadfast in its commitment to providing the public with safe, high quality and efficacious medicines and the healthcare community with adequate information about the value and potential risks of their products.

All IPMG members are fully committed to supporting the medical community in a scientific manner and complying with respective laws and regulations. 

In our continuous effort in creating a level playing field in the Indonesian pharmaceutical industry as well as ensuring a uniform interpretation of the Code, the Ethical Practices Sub-Committee, after careful considerations, has reviewed and made several articles refinement in the IPMG Code of Ethics on July 2017

This refinement is necessary to ensure full alignment with the new decree of Ministry of Health regarding sponsorship, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practices, as well as the “Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector”.

IPMG has been adopting stringent practices and taking compliance measures over the past years. These standard practices should apply to all IPMG member companies.

We believe that the IPMG Code of Ethics, effective as of January 1, 2019, will improve health care services and benefit patients in Indonesia.

Download File :
IPMG Code of Ethics January 2019 Revision

Q: Does this Code of Conduct regulate communication with the public?

A: No. This Code of Conduct regulates interactions with the health professional and promotion of pharmaceutical products. If direct promotion to the public is permitted, it shall be governed by laws, regulations, and / or related codes of ethics. All IPMG members must certainly comply with the law, regulations and / or the code of ethics.


Q: For whom this Code applies?

A: This Code of Ethics applies to all IPMG members. Pharmaceutical companies that are not members of the IPMG are out of scope of this Code. The company and other marketing organizations for products or services, are encouraged to follow ethical promotion standards similar to those specified in this Code of Ethics.


Q: Why doesn't the Code of Ethics cover public disease campaigns?

A: This Code of Conduct regulates interactions with the health profession and promotion of pharmaceutical products. A disease campaign to the public may not promote certain pharmaceutical products. Although not covered by this Code, disease campaigns shall bind to and comply with applicable laws and regulations.



Code Of Conduct
Counterfeit Drugs
Medical Representatives Training
» Hainan Province, Hengda Health and Korean Yuanchen Signs Strategic Cooperation Agreement
Boao, China - In the evening on March 29, Hong Kong listed company New Media (HK.708) (to be changed into Hengda Health Industry Co., Ltd.) announced that it has signed a strategic investment cooperation framework agreement with the Management Committee of the pioneer district of the international medical tourism in Lecheng, Boao, Hainan Province; and Korean Yuanchen Medical Cosmetology Group on March 28 to establish an international medical cosmetology and anti-aging center at the above mentioned pioneer district. An original report from Sina Leju follows.

More » 
» BPOM seizes Rp 150 m worth of fake drugs distributed online
The National Drug and Food Monitoring Agency (BPOM), in conducting its fifth Pangea Operation, has seized thousands of illegal and fake drugs marketed online.

BPOM chairwoman Lucky S.Slamet said Monday that during the operation, her agency had identified 83 websites that allegedly distributed illegal and fake drugs, up from the 30 sites it uncovered during the previous Pangea Operation in 2011. Read full article here .
More » 
March 2019

Copyright © 2013 International Pharmaceutical Manufacturers Group